Last reviewed · How we verify
NCT05943509
Hearing Program in Primary Care
NA trial testing Alternative rehabilitation strategies in Deafness in 120 participants. Participants enrolled and being followed up; not accepting new ones.
15 January 2026
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 15 February 2024 |
| Primary completion | 15 January 2026 |
| Estimated completion | 15 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Alternative rehabilitation strategies
- Usual Care
Conditions studied
- Deafness — all drugs for Deafness →
Sponsor
NYU Langone Health — full company profile →
Who can join
60 and older, any sex, with Deafness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
During a primary care visit, investigators will screen and identify participants with hearing loss and then randomize to a) counseling on accessible assistive listening devices or b) referral to traditional audiology care pathway alone.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Study protocol: feasibility of a hearing program in primary care for underserved older adults.
Friedmann DR, Diminich LN, Spitzer ER, Ajmal S, et al · · 2026 · PMID 41736137 · DOI 10.1186/s40814-026-01773-2
Verify or expand the search:
- PubMed search for NCT05943509
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deafness
Currently open trials in the same condition.
- NCT06088953 — EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER · NA · recruiting
- NCT06960616 — Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy · NA · recruiting
- NCT05808543 — BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants · NA · recruiting
- NCT05670496 — Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Di · recruiting
- NCT05867173 — Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05943509 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 6 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05943509.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing